Stocks · Health care · Surgical & Medical Instruments & Apparatus

Heartflow, Inc.

HTFL Clue Score58
United States Fiscal year ends December CIK 0001464521 Results filed 13 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Campbell Rogers
22 Oct 2026
Chief Medical Officer
Sold after exercise
23,933
$55.01
$1.32M
John C.M. Farquhar
12 Oct 2026
Chief Executive Officer
Sold on a plan
38,900
$49.57
$1.93M
Campbell Rogers
18 Sep 2026
Chief Medical Officer
Sold after exercise
19,682
$50.15
$987.05K
Vikram Verghese
18 Sep 2026
Chief Financial Officer
Sold on a plan
16,766
$50.75
$850.93K
Vikram Verghese
17 Sep 2026
Chief Financial Officer
Sold on a plan
7,579
$50.11
$379.82K
Vikram Verghese
15 Sep 2026
Chief Financial Officer
Sold on a plan
668
$50.01
$33.41K
Vikram Verghese
14 Sep 2026
Chief Financial Officer
Sold on a plan
4,593
$50.24
$230.74K
Vikram Verghese
11 Sep 2026
Chief Financial Officer
Sold on a plan
29,714
$50.06
$1.49M
John C.M. Farquhar
11 Sep 2026
Chief Executive Officer
Sold on a plan
3,890
$50.00
$194.50K
John C.M. Farquhar
10 Sep 2026
Chief Executive Officer
Sold on a plan
35,010
$46.42
$1.63M
Vikram Verghese
8 Sep 2026
Chief Financial Officer
Sold on a plan
6,640
$50.03
$332.21K
Vikram Verghese
3 Sep 2026
Chief Financial Officer
Sold on a plan
27,540
$49.69
$1.37M
Vikram Verghese
2 Sep 2026
Chief Financial Officer
Sold on a plan
5,876
$50.60
$297.33K
John C.M. Farquhar
21 Aug 2026
Chief Executive Officer
Sold on a plan
27,230
$50.00
$1.36M
John C.M. Farquhar
18 Aug 2026
Chief Executive Officer
Sold on a plan
32,676
$45.00
$1.47M
Campbell Rogers
17 Aug 2026
Chief Medical Officer
Sold after exercise
9,219
$41.23
$380.10K
John C.M. Farquhar
14 Aug 2026
Chief Executive Officer
Sold on a plan
15,560
$39.06
$607.77K
John C.M. Farquhar
10 Aug 2026
Chief Executive Officer
Sold on a plan
22,562
$28.31
$638.73K
John C.M. Farquhar
30 Jul 2026
Chief Executive Officer
Exercised, kept
9,737
$9.58
$93.28K
John C.M. Farquhar
30 Jul 2026
Chief Executive Officer
Exercised, kept
18,694
$2.22
$41.50K
John C.M. Farquhar
30 Jul 2026
Chief Executive Officer
Exercised, kept
2,789
$8.33
$23.23K
Vikram Verghese
27 Jul 2026
Chief Financial Officer
Exercised, kept
22,522
$2.22
$50.00K
Jeffrey C Lightcap
24 Jul 2026
Director
Exercised, kept
47,420
$19.00
$900.98K
Timothy C Barabe
22 Jul 2026
Director
Exercised, kept
3,710
$19.00
$70.49K
Vikram Verghese
21 Jul 2026
Chief Financial Officer
Exercised, kept
22,522
$2.22
$50.00K
Timothy C Barabe
17 Jul 2026
Director
Exercised, kept
5,000
$19.00
$95.00K
Campbell Rogers
15 Jul 2026
Chief Medical Officer
Sold after exercise
9,219
$25.72
$237.11K
John C.M. Farquhar
10 Jul 2026
Chief Executive Officer
Sold on a plan
22,562
$27.75
$626.10K
William C Weldon
8 Jul 2026
Director
Exercised, kept
17,123
$8.33
$142.63K
William C Weldon
8 Jul 2026
Director
Exercised, kept
17,123
$8.33
$142.63K
William C Weldon
8 Jul 2026
Director
Exercised, kept
17,123
$8.33
$142.63K
John C.M. Farquhar
24 Jun 2026
Chief Executive Officer
Sold on a plan
38,900
$35.00
$1.36M
Campbell Rogers
15 Jun 2026
Chief Medical Officer
Exercised, kept
10,000
$2.22
$22.20K
John C.M. Farquhar
10 Jun 2026
Chief Executive Officer
Sold on a plan
22,562
$28.50
$643.02K
Campbell Rogers
18 May 2026
Chief Medical Officer
Sold after exercise
9,219
$28.34
$261.27K
John C.M. Farquhar
11 May 2026
Chief Executive Officer
Sold on a plan
22,562
$29.12
$657.01K
Bain Capital Life Sciences Investors, LLC
30 Apr 2026
10% owner
Sell indirect
56,224
$30.05
$1.69M
Bain Capital Life Sciences Investors, LLC
30 Apr 2026
10% owner
Sell indirect
892,533
$29.18
$26.04M
Bain Capital Life Sciences Investors, LLC
29 Apr 2026
10% owner
Sell indirect
797,133
$29.37
$23.41M
Bain Capital Life Sciences Investors, LLC
28 Apr 2026
10% owner
Sell indirect
254,110
$30.51
$7.75M
John C.M. Farquhar
10 Apr 2026
Chief Executive Officer
Sold on a plan
22,562
$26.72
$602.86K
Campbell Rogers
1 Apr 2026
Chief Medical Officer
Sold after exercise
64,533
$24.64
$1.59M
Campbell Rogers
19 Mar 2026
Chief Medical Officer
Sold after exercise
64,533
$25.69
$1.66M
John C.M. Farquhar
18 Mar 2026
Chief Executive Officer
Sold on a plan
9,725
$25.00
$243.13K
Timothy C Barabe
11 Mar 2026
Director
Exercised, kept
8,667
$2.22
$19.24K
John C.M. Farquhar
10 Mar 2026
Chief Executive Officer
Sold on a plan
12,837
$22.66
$290.89K
Julie A Cullivan
5 Mar 2026
Director
Sold on a plan
9,122
$25.00
$228.05K
Timothy C Barabe
17 Feb 2026
Director
Exercised, kept
2,497
$8.33
$20.80K
Campbell Rogers
12 Feb 2026
Chief Medical Officer
Sold after exercise
65,153
$24.49
$1.60M
John C.M. Farquhar
10 Feb 2026
Chief Executive Officer
Sold on a plan
22,562
$27.46
$619.55K
Julie A Cullivan
5 Feb 2026
Director
Sold on a plan
8,000
$27.32
$218.56K
Bain Capital Life Sciences Investors, LLC
4 Feb 2026
10% owner
Sell indirect
2,000,000
$28.05
$56.10M
Jeffrey C Lightcap
16 Dec 2025
Director
Buy
40,000
$26.34
$1.05M
Bain Capital Life Sciences Investors, LLC
11 Aug 2025
10% owner
Exercised, kept indirect
433,924
$15.20
$6.60M

What was left out

Form 4 filings counted 76
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 25
Sales straight out of an exercise 8
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 35,069,055
History held since 11 Aug 2025